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        The processes of tissue remodeling, wound 
healing, and removal of damaged cells rely on 
cell death by apoptosis. Apoptosis entails a highly 
ordered process characterized by cell shrinkage, 
retention of organelles, nuclear chromatin con-
densation, and fragmentation, as well as redistri-
bution of phosphatidylserine (PS) on the plasma 
membrane (  1, 2  ). Under homeostatic condi-
tions, APCs such as macrophages and DCs bind 
and ingest apoptotic cells (ACs) using a vari-
ety of receptors, including Mer tyrosine kinase 
(MerTK), the PS receptor, scavenger receptor-A 
(SR-A), CD36, and       v        5   integrin (  3  –  5  ). In this 
way, the breakdown and release of potentially 
immunogenic self-antigens by ACs is avoided (  6  ). 
Indeed, ineffi   cient clearance of ACs has been 
linked to autoimmunity (  7  ). 
  The binding and ingestion of ACs also re-
sults in immunoregulation of APCs to further 
promote self-tolerance. For instance, activation 
of macrophages is blocked and TGF-     secretion 
is induced by ACs (  8, 9  ). Similarly, immature 
DCs become refractory to subsequent stimula-
tion upon encounter with ACs, and maintain 
a   “  tolerogenic  ”   phenotype characterized by 
low levels of MHC, CD40, CD80, and CD86 
expression and the lack of proinfl  ammatory 
cytokine secretion (  10  –  12  ). Consequently, these 
DCs are unable to eff  ectively stimulate naive T 
cells or promote type 1 CD4  +   T cell diff  erenti-
ation. In the nonobese diabetic (NOD) mouse 
model of autoimmune diabetes for example, 
induction of limited apoptosis of pancreatic      
cells prevents progression of the diabetogenic 
response. Lack of diabetes correlates with the 
establishment of tolerogenic DCs, and subsequent 
induction of immunoregulatory T cells (  13  ). 
  The Tyro3, Axl, and MerTK (TAM) family 
of receptor tyrosine kinases (RTKs) has been re-
ported to regulate homeostatic activation of mac-
rophages and DCs. Mice lacking all three RTKs 
exhibit systemic autoimmunity marked by highly 
activated APCs in vivo (  14  ). MerTK, which 
CORRESPONDENCE  
 Roland  Tisch: 
 rmtisch@med.unc.edu
  Abbreviations used: AC, apop-
totic cell; BMDC, BM-derived 
DC; DT, diphtheria toxin; 
DTR, DT receptor; Gas6, 
growth arrest  –  specifi  c protein-6; 
MerTK, Mer tyrosine kinase; 
NOD, nonobese diabetic; PLN, 
pancreatic lymph node; PS, 
phosphatidylserine; RTK, recep-
tor tyrosine kinase; RPE, retinal 
pigment epithelial cell; sDC, 
splenic DC; STZ, streptozotocin. 
    P. Sen  ’  s present address is Division of Cell Biology and 
Immunology, Institute of Microbial Technology, Sector-39A, 
Chandigarh, 160036, India. 
    The online version of this article contains supplemental material.   
  MerTK is required for apoptotic cell  –
  induced T cell tolerance 
    Mark A.     Wallet  ,    1       Pradip     Sen  ,    1       Rafael R.     Flores  ,    1      Yaming     Wang  ,    1   
  Zuoan    Yi  ,    1      Yingsu     Huang  ,    1       Clayton E.     Mathews  ,    5       H. Shelton     Earp  ,    2,3   
  Glenn     Matsushima  ,    1,2,4       Bo     Wang  ,    1     and   Roland     Tisch      1,2     
  1  Department of Microbiology and Immunology,   2  UNC Lineberger Comprehensive Cancer Center,   3  Department of Medicine
and Pharmacology,   4  UNC School of Medicine Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599 
  5  Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15213   
  Self-antigens expressed by apoptotic cells (ACs) may become targets for autoimmunity. 
Tolerance to these antigens is partly established by an ill-defi  ned capacity of ACs to inhibit 
antigen-presenting cells such as dendritic cells (DCs). We present evidence that the recep-
tor tyrosine kinase Mer (MerTK) has a key role in mediating AC-induced inhibition of DC 
activation/maturation. Pretreatment of DCs prepared from nonobese diabetic (NOD) mice 
with AC blocked secretion of proinfl  ammatory cytokines, up-regulation of costimulatory 
molecule expression, and T cell activation. The effect of ACs on DCs was dependent on 
Gas6, which is a MerTK ligand. NOD DCs lacking MerTK expression (NOD.MerTK  KD/KD  ) were 
resistant to AC-induced inhibition. Notably, autoimmune diabetes was exacerbated in NOD.
MerTK  KD/KD   versus NOD mice expressing the transgenic BDC T cell receptor. In addition, 
     cell  –  specifi  c CD4  +   T cells adoptively transferred into NOD.MerTK  KD/KD   mice in which      cell 
apoptosis was induced with streptozotocin exhibited increased expansion and differentia-
tion into type 1 T cell effectors. In both models, the lack of MerTK expression was associ-
ated with an increased frequency of activated pancreatic CD11c  +  CD8      +   DCs, which 
exhibited an enhanced T cell stimulatory capacity. These fi  ndings demonstrate that MerTK 
plays a critical role in regulating self-tolerance mediated between ACs, DCs, and T cells. 220 IMMUNOREGULATION OF DENDRITIC CELLS | Wallet et al.
and, in addition to binding MerTK, it also serves as a PS opsonin, 
mediating phagocytosis of ACs (  21  ). 
  Recently, we demonstrated that AC-induced immuno-
regulation of DCs is mediated by selective inhibition of the 
NF-    B pathway, which regulates expression of several genes 
involved in DC activation and maturation (  22  ). Importantly, 
upon binding of ACs, MerTK was shown to transduce signals 
necessary for inhibition of NF-    B activation in BM-derived 
DCs (BMDCs) and splenic DCs (sDCs) (  22  ). With this in mind, 
the current study was performed to determine how MerTK 
regulates DC eff  ector function in response to ACs in vitro and 
in vivo, and in turn the eff  ect this has on T cell self-  tolerance. 
also is expressed by NKT cells, certain epithelial cell types, 
and reproductive tissues, is required for effi   cient phagocytosis 
of ACs by peritoneal macrophages (  5, 15  ). Lupus-like symptoms 
detected in aging C57BL/6 mice in which MerTK expression 
is blocked because of insertion of a neomycin cassette in the 
kinase domain of the   Mertk       gene (MerTK  KD  ), are believed 
to be, in part, the result of ineffi   cient clearance of ACs by 
macrophages (  5, 16  ). Investigation of retinal pigment epithe-
lial cells (RPEs) has also shown that engulfment of apoptotic 
outer segments shed from the photoreceptor is mediated by 
MerTK via recognition of growth arrest  –  specifi  c protein-6 
(Gas6) and protein S (  5, 17  –  20  ). Gas6 is ubiquitously expressed 
    Figure 1.         Activation and IL-12 secretion by MerTK-defi  cient DCs are unaffected by AC pretreatment.   (A) Ex vivo NOD sDCs were co-cultured 
with ACs or left untreated, stimulated for 6 h with IFN     and  1   g/ml LPS for 24 h, and stained for DC subset surface markers and intracellular IL-12. 
(B) BMDCs from NOD or NOD.MerTK  KD/KD   mice were untreated or co-cultured with ACs, stimulated with varying concentrations of LPS for 72 h, and 
IL-12p70 secretion was measured by ELISA. (C) Ex vivo  –  derived sDCs from NOD and NOD.MerTK  KD/KD   mice were untreated or co-cultured with ACs, and then 
treated with 1     g/ml LPS for 72 h and IL-12p70 measured. (D) NOD (open histograms) and NOD.MerTK  KD/KD   (fi  lled histograms) BMDCs were untreated or 
co-cultured with ACs, stimulated with 100 ng/ml LPS for 24 h, and assessed for costimulatory molecule expression on CD11c  +   gated cells. (E) NOD and 
NOD.MerTK  KD/KD   BMDCs were untreated or co-cultured with ACs, stimulated by cross-linking CD40 for 72 h, and IL-12p70 secretion measured. All DCs 
were collected from 10  –  12-wk-old female mice (4  –  8 mice per group). Data are representative of two independent experiments. *, P   <   0.001;   †  , P = 0.011 
(Student ’ s   t   test). Error bars represent the mean ± the SEM.     JEM VOL. 205, January 21, 2008 
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CD4  +   and CD8  +   T cells were isolated from the spleens of 
NOD.BDC (  23, 24  ) and NOD.CL4 (  25  ) TCR transgenic 
mice, respectively. In the absence of ACs, both peptide-pulsed 
NOD and NOD.MerTK  KD/KD   BMDCs stimulated high IL-2 
secretion by BDC CD4  +   (  Fig. 2 A  ) and CL4 CD8  +   (  Fig. 2 B  ) 
T cells.   AC pretreatment, however, signifi  cantly inhibited the 
Our data demonstrate that ACs no longer prevent proinfl  am-
matory cytokine secretion, costimulatory molecule expression, 
and T cell stimulation by MerTK-defi  cient DCs. Additionally, 
the number and activation status of pancreatic CD11c  +  CD8      +   
DCs are increased, and T cell  –  mediated      cell autoimmunity is 
exacerbated in NOD mice lacking MerTK expression in both 
TCR-transgenic and T cell adoptive transfer models. 
    RESULTS   
  MerTK is necessary for AC-induced inhibition of DC 
activation, maturation, and effector function in vitro 
  Studies have demonstrated that ACs inhibit activation and 
maturation of DCs. Indeed, AC pretreatment for 3 h blocked 
LPS-stimulated intracellular IL-12p70 expression in CD11c  + 
CD11b  +   and CD11c  +  CD8      +   sDCs prepared from NOD mice 
(  Fig. 1 A  ).   MerTK expression is readily detected on CD11c  + 
CD11b  +   and CD11c  +  CD8      +   sDCs, but is reduced on plasma-
cytoid DCs (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20062293/DC1). To investigate the role 
of MerTK in AC-induced inhibition of DC eff  ector func-
tion, NOD.MerTK  KD/KD   mice were used as a source of DCs 
lacking MerTK expression. A 17-cM segment of 129/Ola 
Chromosome 2 harboring the MerTK  KD   mutation was intro-
gressed onto the NOD genotype for 11 backcross generations 
(  22  ). Pretreatment of NOD BMDCs with ACs for 3 h com-
pletely inhibited LPS-stimulated IL-12p70 secretion that 
otherwise was detected in cultures of NOD BMDCs treated 
with LPS-alone (  Fig. 1 B  ). In contrast, NOD.MerTK  KD/KD   
BMDCs secreted similar levels of IL-12p70 in response to 
LPS, regardless of AC pretreatment (  Fig. 1 B  ). ACs also blocked 
LPS-stimulated IL-12p70 secretion by sDCs prepared from 
NOD but not NOD.MerTK  KD/KD   mice (  Fig. 1 C  ). Similarly, 
AC pretreatment inhibited secretion of other proinfl  amma-
tory cytokines such as TNF     (  22  ) and IL-1    /         (unpublished 
data) in NOD and not MerTK  KD/KD   DCs. LPS-stimulated 
up-regulation of CD40, CD80, and CD86 expression was also 
inhibited by AC pretreatment of NOD BMDCs (  Fig. 1 D  , 
open histograms). In contrast, AC pretreatment had no signi-
fi  cant eff  ect on the induction of costimulatory molecule ex-
pression by LPS-stimulated NOD.MerTK  KD/KD   BMDCs (  Fig. 
1 D  , fi  lled histograms). 
  To rule out the possibility that AC-induced inhibition was 
specifi  c for LPS stimulation, NOD versus NOD.MerTK  KD/KD   
BMDCs treated with anti-CD40 mAb were compared. Cross-
linking with anti-CD40 mAb induced IL-12p70 secretion by 
NOD BMDCs that was signifi  cantly reduced by AC pretreat-
ment (P   <   10      3  ;   Fig. 1 E  ).Conversely, anti-CD40 mAb-stim-
ulated IL-12p70 secretion by NOD.MerTK  KD/KD   BMDCs 
was not aff  ected by AC pretreatment (  Fig. 1 E  ). These results 
indicate that in the absence of MerTK expression, DCs are re-
sistant to the inhibitory eff  ect of ACs on secretion of pro-
infl  ammatory cytokines and up-regulation of costimulatory 
molecule expression. 
  Next, the eff  ect of AC pretreatment on the capacity of 
NOD and NOD.MerTK  KD/KD   BMDCs to stimulate CD4  +   
and CD8  +   T cells in vitro was investigated. For this purpose, 
    Figure 2.         T cell stimulation by MerTK-defi  cient DCs is not inhib-
ited by ACs.   NOD and NOD.MerTK  KD/KD   BMDCs were co-cultured or not 
with ACs, plus 0.1   μ  g/ml BDC peptide and BDC CD4  +   T cells (A and C) or 
0.1   μ  g/ml HA peptide and CL4 CD8  +   T cells (B and D) for 72 h, and IL-2 
secretion was measured by ELISA. Varying numbers of BMDCs were cul-
tured with 10  6   BDC  CD4 +   (C) or CL4 CD8  +   (D) T cells. (C and D) Filled and 
open squares are NOD BMDCs and NOD BMDCs plus ACs, respectively; 
fi  lled and open circles are NOD.MerTK  KD/KD   BMDCs and NOD.MerTK  KD/KD  
BMDCs plus ACs, respectively. BMDCs were isolated from 10  –  12  –  wk-old 
female mice (4  –  8 mice per group). Data are representative of two inde-
pendent experiments. *, P   <   0.001 (Student  ’  s   t   test). Error bars represent 
the mean ± the SEM.         222 IMMUNOREGULATION OF DENDRITIC CELLS | Wallet et al.
either BDC CD4  +   or CL4 CD8  +   T cells compared with  peptide-
pulsed only cultures (  Fig. 2, A and B  ). Similar results were 
obtained when the number of NOD and NOD.MerTK  KD/KD   
BMDCs were titrated (  Fig. 2, C and D  ). 
capacity of peptide-pulsed NOD BMDCs to stimulate BDC 
CD4  +   (P   <   10      3  ) and CL4 CD8  +   (P   <   10      3  ) T cells (  Fig. 2, 
A and B  ). In contrast, AC pretreatment of peptide-pulsed 
NOD.MerTK  KD/KD   BMDCs had no eff  ect on IL-2 secretion by 
    Figure 3.         Antibody blockade of MerTK prevents AC-induced inhibition of DCs.   (A) NOD BMDCs were pretreated with isotype control or anti-
MerTK antibody for 30 min. NOD BMDCs were then treated with ACs for the specifi  ed times and MerTK immunoprecipitated from a whole cell lysate with 
anti-MerTK antibody. Phosphorylation of MerTK (top) was determined by Western blot using an anti  –  phospho-tyrosine antibody, and the same blot re-
probed to detect MerTK protein (bottom). (B  –  E) NOD    BMDCs were incubated with either isotype control or anti-MerTK antibody before co-culture with ACs. 
BMDCs were stimulated with 100 ng/ml LPS and IL-12p70 secretion measured by ELISA 72 h later (B) or costimulatory molecule surface expression mea-
sured via FACS 24 h later (C). Open histograms represent untreated DCs and fi  lled histograms represent the indicated treatment group plus LPS. BMDCs 
were cultured with (D) BDC peptide and BDC CD4  +   T cells or (E) HA peptide and CL4 CD8  +   T cells for 72 h, and IL-2 secretion measured by ELISA. BMDCs 
were isolated from 10  –  12 wk-old female mice (4  –  8 per group). Data are representative of two independent experiments     *, P   <   0.001 (Student  ’  s   t   test). 
Error bars represent the mean ± the SEM.         JEM VOL. 205, January 21, 2008 
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present on ACs even under serum-free culture conditions, a 
direct role for Gas6 in AC-mediated inhibition of DCs was 
established by using a blocking anti-Gas6 polyclonal antibody. 
Pretreatment of ACs with anti-Gas6, but not an isotype con-
trol antibody, blocked the capacity of ACs to inhibit LPS-
stimulated IL-12p70 secretion by NOD BMDCs (  Fig. 4 C  ). 
  The lack of sensitivity of NOD.MerTK  KD/KD   DCs to AC 
pretreatment could be caused by an artifact of DCs develop-
ing in the absence of MerTK expression, and/or the genetic 
background of the mice. To rule out these possibilities, the 
eff   ect of a blocking anti-MerTK polyclonal antibody on 
NOD and BALB/c BMDCs was assessed. The inhibitory ac-
tivity of the polyclonal antibody was verifi  ed by demonstrat-
ing that phosphorylation of MerTK induced by ACs was 
inhibited by treating NOD DCs with anti-MerTK, but not 
an isotype control antibody (  Fig. 3 A  ).   Despite AC pretreat-
ment, LPS-stimulated IL-12p70 secretion (  Fig. 3 B  ) and up-
regulation of costimulatory molecule expression (  Fig. 3 C  ) 
were readily detected in NOD BMDCs incubated with anti-
MerTK antibody. Furthermore, ACs failed to inhibit stimu-
lation of BDC CD4  +   (  Fig. 3 D  ) and CL4 CD8  +   (  Fig. 3 E  ) T cells 
by NOD BMDCs incubated with the anti-MerTK, but not 
the isotype control antibody. 
  Next, BALB/c DCs were treated with blocking anti-MerTK 
or isotype control antibody before AC treatment. Similar to 
NOD DCs, ACs prevented LPS-stimulated up-regulation 
of costimulatory molecule expression (Fig. S2 A, available at 
http://www.jem.org/cgi/content/full/jem.20062293/DC1) 
and IL-12p70 secretion (Fig. S2 B), and inhibited T cell stim-
ulation (Fig. S2 C) by BALB/c BMDCs. Anti-MerTK, but 
not isotype control antibody, however, blocked AC-induced 
inhibition of IL-12p70 and T cell stimulation by BALB/c DCs 
(Fig. S2, A  –  C). Together, these fi  ndings demonstrate that AC-
induced inhibition of activation, maturation, and eff  ector func-
tion of BMDCs and sDCs in vitro is dependent on MerTK. 
  AC-induced inhibition of DCs is Gas6 dependent 
  Gas6 binds MerTK, and some evidence indicates that protein 
S is also a MerTK ligand (  26  –  29  ). Other yet to be identifi  ed 
ligands have also been proposed. Initially, protein S, which is 
found in serum, was investigated. Protein S mRNA expression 
by AC was not detected via RT-PCR (Fig. S3 A, available at 
http://www.jem.org/cgi/content/full/jem.20062293/DC1), 
and LPS-stimulated IL-12p70 secretion by NOD BMDCs 
was inhibited by ACs despite serum-free culture conditions 
(Fig. S3 B). These results indicate that protein S is not nec-
essary for MerTK binding of ACs, and they are consistent 
with recent observations by our group that Tyro3, and not 
MerTK, binds protein S (  30  ). Whether Gas6 functioned 
as a MerTK ligand for ACs was then tested. Gas6 has been 
reported to bind PS (  31  ), which would be exposed on the 
inverted plasma membrane of ACs. Accordingly, Gas6 surface 
expression on apoptotic thymocytes induced in vitro via      ir-
radiation or prepared directly from the thymus was measured 
by FACS. Apoptotic thymocytes were identifi  ed by costain-
ing with a VAD-FMK-FITC conjugate. Gas6 was detected 
on the surface of apoptotic thymocytes regardless of whether 
apoptosis was induced in vitro or in vivo (  Fig. 4 A  ).   Further-
more, Gas6 protein expression as determined by Western blot 
was induced in a temporal manner in irradiated thymocytes 
cultured under serum-free conditions (  Fig. 4 B  ). Because 
protein S may bind to thymocytes in vivo and therefore be 
    Figure 4.         AC-expressed Gas6 is necessary for DCs inhibition.  
(A) FITC-VAD-FMK  –  negative (nonapoptotic) thymocytes (fi  lled histograms) 
and FITC-VAD-FMK  –  positive (apoptotic) thymocytes (open histograms) 
were surface-stained with isotype control (top) or anti-Gas6 antibody 
(bottom). (B) Gas6 (top) and      actin (bottom) protein was detected via 
Western blot in whole-cell lysates prepared from untreated (U/T) thymo-
cytes or apoptotic thymocytes at various times after      irradiation. 10 ng 
of recombinant murine Gas6 protein (rmGas6) was loaded as a positive 
control (note that a truncation causes rmGas6 to have a reduced molecular 
weight compared with endogenous Gas6; see Materials and methods). 
(C) NOD BMDCs were pretreated with ACs incubated with anti-Gas6 or iso-
type control antibody, and LPS-induced (100 ng/ml) IL-12p70 secretion was 
measured via ELISA 72 h later. Thymocytes were isolated from 3  –  4 wk-old 
female NOD mice. BMDCs were isolated from 10  –  12-wk-old female NOD mice 
(4 per group). Data are representative of two independent experiments. 
*, P = 0.005 (Student  ’  s   t   test). Error bars represent the mean ± the SEM.     224 IMMUNOREGULATION OF DENDRITIC CELLS | Wallet et al.
animals (Fig. S4, available at http://www.jem.org/cgi/content/
full/jem.20062293/DC1). Furthermore, a kinetic analysis of 
apoptotic      cell clearance/persistence showed no diff  erence 
between STZ-treated NOD and NOD.MerTK  KD/KD   mice 
(Fig. S5). CFSE-labeled BDC CD4  +   T cells were adoptively 
transferred, and 72 h later, proliferation was measured in the 
draining PLNs. Only limited proliferation of BDC CD4  +   
T cells was detected in NOD recipients treated with either 
STZ or citrate saline (  Fig. 6 A  ).   Similarly, the majority CFSE  +   
BDC CD4  +   T cells (71%) had not proliferated in citrate 
saline  –  treated NOD.MerTK  KD/KD   recipients (  Fig. 6 A  ). In con-
trast, BDC CD4  +   T cells exhibited signifi  cant proliferation in 
NOD.MerTK  KD/KD   mice treated with STZ (  Fig. 6 A  ). Addi-
tionally, the frequency of CFSE  +   IFN    -producing cells was 
These results demonstrate that Gas6 expression is induced 
on the surface of ACs, and that it is required for MerTK-
mediated inhibition of DCs by ACs. 
  MerTK is required to maintain T cell tolerance to apoptotic 
     cells 
  The lack of sensitivity of MerTK  KD/KD   DCs to AC-induced 
inhibition in vitro would be expected to promote autoimmunity 
in vivo. To test this hypothesis, TCR transgenic NOD.BDC 
mice were bred with NOD.MerTK  KD/KD   animals, and the 
development of diabetes was compared in female mice lack-
ing MerTK expression (NOD.MerTK  KD  .BDC) or expressing 
wild-type levels of MerTK (NOD.BDC). Although only 10% 
(1/10) of NOD.BDC female mice developed diabetes over 
52 wk (  Fig. 5 A  ), which is consistent with the diabetes inci-
dence reported for other NOD.BDC colonies, diabetes onset 
was accelerated, and the incidence of diabetes signifi  cantly 
  increased (7/11; P = 0.038,       2  ) in NOD.MerTK  KD  .BDC 
female mice (  Fig. 5 A  ).   Furthermore, ELISPOT demonstrated 
a signifi  cantly (P = 0.002, Student  ’  s   t   test) increased frequency 
of IFN    -secreting CD4  +   T cells in the pancreatic lymph nodes 
(PLNs) of 4 wk-old NOD.MerTK  KD  .BDC versus NOD.BDC 
female mice (  Fig. 5 B  ). 
  One possible explanation for exacerbated      cell auto-
immunity in NOD.MerTK  KD  .BDC mice is that apoptotic      
cells failed to inhibit DC activation and/or maturation, lead-
ing to enhanced activation of BDC CD4  +   T cells. Analysis of 
DCs infi  ltrating the pancreas of 4-wk-old mice demonstrated 
that the number of CD11c  +  CD8      +   DCs was increased in 
NOD.MerTK  KD  .BDC mice (  Fig. 5 C  ). Furthermore, an in-
creased frequency of CD86  HI   and CD80  HI   CD8      +   DCs was 
found among pancreatic CD11c  +  CD8      +   DCs in NOD.
MerTK  KD  .BDC when compared with NOD.BDC female 
mice (  Fig. 5 C  ). No diff  erence, however, was detected in the 
activation status of pancreatic CD11c  +  CD11b  +   DCs (  Fig. 5 C  ) 
in the two groups of mice. These fi  ndings demonstrate that in 
the absence of MerTK expression, enhanced      cell autoimmu-
nity correlated with increased activation and numbers of pan-
creatic CD11c  +  CD8      +   DCs. 
  To better defi  ne events going on between apoptotic      
cells, DCs, and CD4  +   T cells, a model system was established 
in which naive BDC CD4  +   T cells were transferred into either 
4 wk-old NOD or NOD.MerTK  KD/KD   female recipients and 
     cell apoptosis synchronized by treatment with a single dose 
of streptozotocin (STZ). This approach was necessary because 
analysis of NOD.BDC and NOD.MerTK  KD  .BDC mice is 
limited by heavy islet infi  ltration at an early age (i.e., by 3 wk 
of age), and the observation that      cell apoptosis is not syn-
chronized. At 4 wk of age, both NOD and NOD.MerTK  KD/KD   
mice lack islet infi  ltration. NOD and NOD.MerTK  KD/KD   
mice received a single i.p. injection of 120 mg/kg of STZ or 
citrate saline as a vehicle control. STZ at 120 mg/kg induces 
only moderate      cell apoptosis, and the treated NOD mice 
  remain diabetes free (  13  ). Equivalent levels of Gas6 were de-
tected on the surface of the few apoptotic      cells detected in 
untreated mice, and on apoptotic      cells in the STZ-treated 
    Figure 5.         MerTK-defi  cient mice expressing a diabetogenic TCR 
transgene exhibit aggressive insulitis and exacerbated T1D.   (A)  NOD.
BDC (  n   = 10) and NOD.MerTK  KD .BDC  ( n   = 11) female mice were monitored 
for diabetes. *, P = 0.013 (Kaplan-Meir log rank). (B) The frequency of 
IFN    -producing cells within the PLN of NOD.BDC and NOD.MerTK  KD .BDC 
mice was determined by ELISPOT. All mice were 4  –  5-wk-old (5 mice per 
group). Data are representative of two independent experiments.   †  , P = 
0.002 (Student  ’  s   t   test). Error bars represent the mean ± the SEM. (C) Pan-
creatic DCs prepared from 4-wk-old female NOD.BDC and NOD.MerTK  KD .
BDC mice were analyzed by FACS. Percentages for the gated cell popula-
tions are the average of three independent experiments.     JEM VOL. 205, January 21, 2008 
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BDC CD4  +   T cells continued to increase in STZ-treated 
NOD.MerTK  KD/KD   recipients (  Fig. 6, C and D  ). Notably, the 
increased T cell reactivity of transferred CFSE  +   BDC CD4  +   T 
cells in STZ-treated NOD.MerTK  KD/KD   recipients was DC-
dependent, based on experiments using NOD.MerTK  KD/KD   
mice expressing the diphtheria toxin (DT) receptor (DTR) 
transgene driven by the CD11c promoter as recipients. The 
CD11c-DTR transgenic model has been used to transiently 
deplete DCs in vivo upon DT injection (  32  ). NOD.MerTK.
DTR mice were treated with DT or left untreated, and 24 h 
later, mice received STZ and CFSE  +   BDC CD4  +   T cells. As 
demonstrated in   Fig. 6 E  , DT treatment, which induces a 
  >  10-fold reduction of PLN DCs, signifi  cantly reduced prolif-
eration and the frequency of CFSE  +  IFN      +   BDC CD4  +   T cells 
compared with the non-DT treated group of mice. 
markedly increased in STZ-treated NOD.MerTK  KD/KD   recip-
ients (36%) compared with STZ-treated NOD or citrate saline  –
  treated NOD and NOD.MerTK  KD/KD   recipients (    2 to 3%; 
  Fig. 6 B  ). Consistent with these latter fi  ndings, the total 
number of CFSE  +  IFN      +   BDC CD4  +   T cells in the PLN of 
STZ-treated NOD.MerTK  KD/KD   recipients increased with 
time relative to the other groups. At 72 h after transfer, no sig-
nifi  cant diff  erence in the number of CFSE  +   BDC CD4  +   T 
cells among the four treatment groups was detected (  Fig. 6 C  ), 
although the number of CFSE  +  IFN      +   T cells was increased 
in STZ-treated NOD.MerTK  KD/KD   recipients (  Fig. 6 D  ). At 
96 h after transfer, the number of CFSE  +   BDC CD4  +   T cells 
signifi  cantly declined among STZ- and citrate saline  –  treated 
NOD mice, and citrate saline  –  treated NOD.MerTK  KD/KD   
mice. In contrast, both the number of CFSE  +   and CFSE  +  IFN      +   
    Figure 6.              Cell apoptosis in MerTK-defi  cient mice induces CD4  +   T cell proliferation, and type 1 differentiation that is DC dependent.   NOD 
or NOD.MerTK  KD/KD   4  –  6 wk-old female mice were treated with citrate saline control (Cit Sal) or 120 mg/kg STZ. 2.5   ×   10  6   CFSE-labeled BDC CD4  +   T  cells 
were transferred into each mouse, and 72 h later, PLNs were harvested and cell division (A and B) and intracellular IFN     expression (B) were determined 
via FACS. The percentage of CFSE  + CD4 +   T cells is provided for each column in A. The total number of CD4  +   (C)  CFSE +   and (D) CFSE  +   IFN   +   T cells was de-
termined at 72 and 96 h after transfer. (E) NOD.MerTK.DTR mice were treated with DT (4 ng/g body weight) or left untreated, and 24 h later they received 
120 mg/kg STZ and 10  6   CFSE +  BDC CD4  +   T cells. The percentage of IFN    +   (left) and frequency of proliferating CFSE  +  T cells in the PLN were assessed 72 h 
later. Results are the mean of two experiments with groups of four mice each. *, P   <   0.001; **, P = 0.007;   †  , P = 0.005;   †  † ,  P  =  0.002  (Student ’ s   t   test).  Error 
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  CD11c  +  CD8      +   DCs from STZ-treated MerTK-defi  cient NOD 
mice have an increased capacity to stimulate T cells 
  Analysis of pancreatic DCs showed no signifi  cant diff  erence in 
the frequency of CD11c  +  CD11b  +   and CD11c  +  CD8      +   DCs 
in citrate saline  –  treated NOD and NOD.MerTK  KD/KD   recipi-
ents, or STZ-treated NOD recipients (  Fig. 7 A  ).   In contrast, 
an increase in the frequency of pancreatic CD11c  +  CD8      +   
DCs was detected in STZ-treated NOD.MerTK  KD/KD   recipi-
ents (  Fig. 7 A  ). The frequency of CD11c  +  CD8      +   DCs ex-
pressing elevated surface CD80 and CD86 in the pancreas 
(  Fig. 7 A  ), and intracellular IL-12 in the PLN (  Fig. 7 B  ) was 
also increased in STZ-treated NOD.MerTK  KD/KD   recipients 
relative to the other three groups. These fi  ndings indicate that 
enhanced proliferation and IFN     expression by CFSE  +   BDC 
CD4  +   T cells transferred into STZ-treated NOD.MerTK  KD/KD   
mice is DC dependent and correlates with an increased fre-
quency of activated CD11c  +  CD8      +   DCs. 
  To determine whether acquisition of      cell antigens 
in vivo by NOD.MerTK  KD/KD   DCs promoted      cell  –  specifi  c 
T cell expansion, mice were treated with STZ as above, DCs 
were sorted via FACS from the pancreas, and the sorted DCs 
were cultured with CFSE  +   BDC CD4  +   T cells (without exog-
enous peptide). As demonstrated in   Fig. 8 A  , a signifi  cant in-
crease in proliferation was detected in cultures prepared with 
DCs isolated from STZ-treated NOD.MerTK  KD/KD   as com-
pared with NOD mice (P = 0.025, Student  ’  s   t   test).   Next, 
pancreatic CD11c  +  CD11b  +   and CD11c  +  CD8      +   DCs were 
sorted, and the capacity to stimulate BDC CD4  +   T cells in vi-
tro was tested, again, in the absence of exogenous antigen. 
Similar to results obtained with a pool of sorted pancreatic DCs 
(  Fig. 8 A  ), no increase in CFSE  +   BDC CD4  +   T cell prolifera-
tion was seen for either CD11c  +  CD11b  +   or CD11c  +  CD8      +   
DCs prepared from STZ- versus citrate saline  –  treated NOD 
mice (  Fig. 8 B  ). Strikingly, a 9.7-fold increase in BDC CD4  +   
T cell proliferation was observed for CD11c  +  CD8      +   DCs 
sorted from STZ-treated compared with citrate saline  –  treated 
NOD.MerTK  KD/KD   mice (  Fig. 8 B  ). On the other hand, only 
a marginal increase (1.8-fold) in CD4  +   T cell proliferation was 
detected for CD11c  +  CD11b  +  DCs sorted from the pancreas of 
NOD.MerTK  KD/KD   mice treated with STZ versus citrate 
saline (  Fig. 8 B  ). These data demonstrate that DCs lacking 
MerTK expression, upon encounter with apoptotic      cells, 
drive expansion of      cell  –  specifi  c CD4  +   T cells. Furthermore, 
     cell  –  specifi  c CD4  +   T cell stimulation is predominately me-
diated by CD11c  +  CD8      +   DCs in NOD.MerTK  KD/KD   mice. 
    DISCUSSION   
  ACs provide a continuous source of self-antigen, which can 
be ingested, processed, and presented by DCs (  4  ). Autoim-
mune reactivity to these self-antigens, however, is blocked by 
    Figure 7.         An increased frequency of activated CD11c  +  CD8      +   DCs 
is detected in STZ-treated MerTK-defi  cient recipient mice.  
(A and B) 5   ×   10  6   BDC  CD4 +   T cells were transferred, and after 72 h, 
CD11c  + CD11b +   and  CD11c + CD8   +   DCs were isolated from the pancreas 
and stained for CD11b, CD8    , CD80 and CD86 (A), or PLN CD11c  + CD8   +  
DCs stained for intracellular IL-12 p40/p70, and the total number of IL-12 
expressing CD11c  + CD8   +   DCs determined per PLN (B). *, P = 0.026 
(Student ’ s   t   test). Error bars represent the mean ± the SEM.     
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Furthermore, Gas6 expression was detected on the surface of 
apoptotic thymocytes and      cells (  Figs. 4 A   and S4), and a 
  direct role for this PS opsonin was shown by blocking the 
inhibitory eff  ect of ACs via anti-Gas6 antibody (  Fig. 4 C  ). 
Importantly, in the absence of AC pretreatment, NOD and 
NOD.MerTK  KD/KD   DC activation and APC function did not 
signifi  cantly diff  er (  Figs. 1 and 2  ). Based on these data, we 
conclude that MerTK primarily serves to bind ACs and trans-
duce signals that block subsequent activation and maturation 
in DCs. In contrast to RPE and certain subsets of macrophages, 
however, DCs do not require MerTK for effi   cient phago-
cytosis of ACs (Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20062293/DC1) (  16, 30  ). 
  The roles of and mechanisms by which TAM RTKs reg-
ulate innate cell activation and/or function are complex, and 
clearly cell-type dependent. Recent work by Ivashkiv et al. 
demonstrated that IFN    -mediated inhibition of TNF     se-
cretion in macrophages is caused by Axl binding of Gas6 or 
the capacity of ACs to inhibit subsequent DC activation and 
maturation (  10  –  12, 30, 33  ). MerTK is involved in phagocy-
tosis of ACs by certain subsets of macrophages (  5, 15, 34  ) and 
RPEs (  35  ). In addition, MerTK and TAM family members 
Axl and Tyro3 have been shown to regulate homeostatic ac-
tivation of innate eff  ector cells (  14, 16  ). More recently, we 
have demonstrated that ACs immunoregulate DCs in part by 
preventing activation of the NF-    B pathway via MerTK-
mediated signaling events (  22  ). Accordingly, the role for MerTK 
in AC-induced immunoregulation of DCs and self-tolerance 
was investigated. 
  In vitro analyses of BMDCs and ex vivo sDCs demon-
strate an essential role for MerTK in AC-induced inhibition 
of DC activation, maturation, and eff  ector function. AC pre-
treatment of NOD, but not NOD.MerTK  KD/KD   DCs or DCs 
incubated with anti-MerTK antibody inhibited proinfl  amma-
tory cytokine secretion, up-regulation of costimulatory mole-
cule expression, and T cell stimulation (  Figs. 1  –  3   and S2). 
    Figure 8.         CD11c  +  CD8      +   DCs from STZ-treated NOD.MerTK  KD/KD   mice exhibit an increased T cell stimulatory capacity.   NOD or NOD.MerTK  KD/KD  
mice were treated with citrate saline or 120 mg/kg STZ, and 18 h after treatment, pancreatic DCs (A) or CD11c  + CD11b +   or  CD11c + CD8   +   DC subsets (B) 
were purifi  ed and co-cultured with CFSE  +   BDC  CD4 +   T cells (without exogenously added peptide) for 72 h. Negative control (BDC CD4  +  T cells only) and 
positive control (BDC CD4  +  T cells + BDC peptide-pulsed DCs) were included. Data represent 3 replicate experiments, with 5 4  –  5-wk-old female mice per 
treatment group in each experiment. *, P = 0.025 (Student  ’  s   t   test). Error bars represent the mean ± the SEM.     228 IMMUNOREGULATION OF DENDRITIC CELLS | Wallet et al.
NOD.MerTK  KD/KD   mice (Fig. S5) ruling out the possibility 
that   “  antigen-load  ”   infl  uenced BDC CD4  +   T cell expansion 
and IFN     expression in a disparate manner among the respec-
tive groups. Therefore, the lack of MerTK expression results 
in the development of pathogenic      cell  –  specifi  c type 1 T 
eff  ector cells once      cells are undergoing apoptosis. 
  Several observations indicate that MerTK-defi  cient CD11c  + 
CD8      +   DCs contribute to      cell autoimmunity in the two 
model systems studied. For instance, in both NOD.MerTK  KD  .
BDC mice and STZ-treated NOD.MerTK  KD/KD   mice, the 
frequency and activation status of CD11c  +  CD8      +   DCs was 
increased relative to CD11c  +  CD11b  +   DCs (  Fig. 5 C and 
Fig. 7 A  ). Furthermore, pancreatic CD11c  +  CD8      +   DCs from 
STZ-treated NOD.MerTK  KD/KD   mice exhibited an increased 
T cell stimulatory capacity in vitro compared with CD11c  + 
CD11b  +   DCs from the same mice, or CD11c  +  CD8      +   and 
CD11c  +  CD11b  +   DCs from the other experimental groups 
(  Fig. 8 B  ). Importantly, T cell stimulation was directly depen-
dent on the capacity of the respective DCs to endocytose, 
process, and present antigen derived from STZ-induced apop-
totic      cells in vivo. These results are similar to reports indicat-
ing that CD11c  +  CD8      +   DCs are highly effi   cient at presenting 
antigens derived from ACs (  39, 40  ), and are potent producers 
of IL-12p70 (  41, 42  ). Furthermore, CD11c  +  CD8      +   DCs have 
been implicated in driving      cell autoimmunity (  43  ). 
  Although MerTK-expressing macrophages and NKT cells 
were not directly examined, it is unlikely that these innate 
eff  ectors play a signifi  cant role in promoting      cell auto-
immunity in the two model systems. For instance, no dif-
ference in the number and activation status of CD11b  + 
F4/80  +   macrophages was detected in the PLN or pancreas of 
NOD.BDC versus NOD.MerTK  KD  .BDC mice or NOD 
versus NOD.MerTK  KD/KD   recipients (unpublished data). The 
observation that clearance of apoptotic      cells over a 24-h pe-
riod was similar in STZ-treated NOD or NOD.MerTK  KD/KD   
recipients (Fig. S5) further suggests no signifi  cant defect in 
MerTK-defi  cient macrophages; macrophages are generally 
considered to be the most effi   cient cell type for removal 
of ACs (  6, 44, 45  ). NKT cells have been shown to have an 
immunoregulatory role in T1D, and reduced numbers of 
NKT cells in NOD mice has been linked to diabetes pro-
gression (  43  ). Using CD1d tetramers complexed with an 
    -galactosylceramide peptide, no diff  erence in the number 
of NKT cells was detected under the various conditions 
tested, regardless of MerTK expression (unpublished data). 
Although work by Behrens et al. (  46  ) suggests that MerTK 
is required for activation of NKT cells in vitro, the lack of 
MerTK expression appears to have no signifi  cant eff  ect on 
an already diminished pool of NKT cells in NOD mice. 
Finally, results obtained with NOD.MerTK.DTR mice in 
which proliferation and IFN     expression of adoptively 
transferred BDC CD4  +   T cells in the PLNs were signifi  -
cantly reduced after DT injection and in vivo DC deple-
tion (  Fig. 6 E  ), further demonstrate a primary role for DCs 
in mediating enhanced      cell  –  specifi  c T cell reactivity in 
MerTK-defi  cient NOD mice. Importantly, the frequency of 
ACs, even though MerTK and Tyro3 are expressed and bind 
these ligands (  36  ). Here, IFN     was found to up-regulate Axl, 
which in turn diff  erentially induced the transcriptional sup-
pressor Twist (  36  ). Interestingly, Axl-induced Twist blocked 
TNF     expression by preventing NF-   B binding to the TNF    
gene promoter. As noted above, MerTK binding of ACs in 
DCs also regulates NF-    B  –  dependent transcription, but in 
this case via inhibition of upstream I    B kinase activation in a 
phosphatidylinositol 3-kinase  –  dependent manner (  22  ). These 
fi  ndings suggest that NF-    B is a common target of the TAM 
family in macrophages and DCs and that the mechanism by 
which NF-    B activity is regulated is dependent on the partic-
ular RTK, the context of the signaling events, and cell type. 
  The inability of ACs to block activation and maturation of 
DCs lacking MerTK expression would be expected to break 
T-cell tolerance in vivo. In fact, this was observed in the two 
in vivo model systems studied. In NOD.MerTK  KD  .BDC mice, 
overt diabetes developed at an enhanced frequency and accel-
erated onset, which corresponded with an increased frequency 
of IFN    -secreting CD4  +   T cells in the PLN compared with 
NOD.BDC mice ( Fig. 5, A and B ). Furthermore, BDC CD4  +   
T cells transferred into STZ-treated NOD.MerTK  KD/KD   ex-
hibited enhanced expansion and IFN     expression, resulting in 
a signifi  cantly increased number of type 1 eff  ectors at 96 h after 
transfer compared with the other groups of recipients (  Fig. 6  ). 
Importantly, this eff  ect was dependent on the induction of 
     cell apoptosis because expansion and IFN     expression by 
BDC CD4  +   T cells in citrate saline  –  treated NOD.MerTK  KD/KD   
recipients was limited, and mimicked that of STZ- or citrate 
saline  –  treated NOD recipient mice (  Fig. 6  ). Surprisingly, 
the total number of CFSE  +   BDC CD4  +   T cells in the PLN 
of STZ-treated NOD.MerTK  KD/KD   recipients at 72 h after 
transfer was similar to the other 3 groups (  Fig. 6 C  ), despite 
increased proliferation (  Fig. 6 A  ). This discrepancy was caused 
by enhanced traffi   cking of BDC CD4  +   T cells from the PLN 
into the islets of the STZ-treated NOD.MerTK  KD/KD   recipi-
ents (unpublished data). The marked decrease in the number 
of BDC CD4  +   T cells observed between 72 and 96 h after 
transfer for STZ- or citrate saline  –  treated NOD recipients 
(  Fig. 6, C and D  ) is typical of antigen-induced tolerance, in 
which T cells undergo expansion and then contraction. This 
result is consistent with a report by the Glaichenhaus group 
demonstrating that STZ-induced      cell apoptosis in young 
NOD mice induces tolerogenic DCs that prevent the ex-
pansion and development of pathogenic T eff  ector cells (  13  ). 
Indeed, pancreatic DCs from STZ-treated NOD.MerTK  KD/KD   
recipients exhibited a typical   “  proinfl  ammatory  ”   phenotype 
based on increased expression of costimulatory molecules and 
IL-12 relative to STZ-treated NOD recipients (  Figs. 7 and 8  ). 
Furthermore, real-time PCR analysis showed that TNF     and 
IL-1     mRNA expression was increased 9.5- and 9.9-fold, re-
spectively, in DCs sorted from the pancreas of STZ-treated 
NOD.MerTK  KD/KD   versus NOD recipients (unpublished data). 
The latter is noteworthy in view of the cytotoxic eff  ect TNF     
and IL-1     have on      cells (  37, 38  ). Importantly, the frequency 
of apoptotic      cells was similar in STZ-treated NOD and JEM VOL. 205, January 21, 2008 
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onset and frequency as wild-type NOD mice. Use of mice was approved 
by the Institutional Animal Care and Use Committee of the University of 
North Carolina at Chapel Hill. 
  Preparation of BMDCs and sDCs.     BMDCs and sDCs were prepared 
from male or female mice between 8  –  12 wk of age as described (  52  ). In 
brief, BM cells were fl  ushed from tibias and femurs, and RBCs were lysed. 
BM cells were cultured for 8 d in RPMI 1640 complete media (10% FBS, 
penicillin/streptomycin,   l-  glutamine, sodium pyruvate, nonessential amino 
acids, and 2-mercaptoethanol) with 10 ng/ml GM-CSF (PeproTech) and 
10 ng/ml IL-4 (PeproTech). On day 8, BMDCs were washed and cultured 
in RPMI complete media (without cytokines) for experiments. 
  FACS.     The following monoclonal antibodies used for FACS were pur-
chased from BD Biosciences: anti  –  CD40-FITC,   –  CD86-FITC,   –  CD80-
FITC,   –  CD11c-PE,   –  CD11c-APC, and   –  IFN    -PE. Polyclonal affi   nity 
purifi  ed goat anti-MerTK (AF591), anti-Gas6, and normal goat IgG were 
purchased from R  &  D Systems. Biotinylated anti  –  goat IgG was obtained 
from Vector Laboratories. Anti-CD16/32 for Fc blocking, PerCP-streptavidin 
and PE-streptavidin were purchased from BD Biosciences. Stained cells were 
analyzed on a FACScan or FACSCalibur (BD Biosciences) using Summit 
Software (Dako). 
  Pretreatment of DCs with ACs.     Thymocytes prepared from 4  –  6-wk-old 
mice were adhered to plastic for 2 h to remove DCs and macrophages,      ir-
radiated at 600 R, and cultured in base medium for 12 h. FACS demonstrated 
  >  90% apoptotic and   <  10% necrotic thymocytes based on Annexin V and 
propidium iodide staining. Apoptosis was confi  rmed via DNA fragmentation 
analysis. DCs were co-cultured with ACs at a ratio of 1:10 (DC:AC) for 3 h. 
In some experiments, DCs were treated with anti-MerTK antibody before 
AC incubation. In brief, DCs (5   ×   10  6  /well) were incubated with anti  –  mouse 
Fc    III/II (BD Biosciences) in 6-well ultra-low cluster plates for 0.5 h at 37  °  C 
to block Fc receptor binding. DCs were treated for 1 h at 37  °  C with 20   μ  g 
of goat anti-MerTK antibody or goat IgG, which is an isotype control. Alter-
natively, some AC samples were pretreated with 20   μ  g polyclonal anti-Gas6 
or goat IgG for 30 min before co-culture with DCs. In other experiments, 
DCs were co-cultured with ACs in serum-free HL1 media (Cambrex) to 
eliminate serum-derived protein S. 
  Measurement of IL-12 production from DCs.     DCs (9   ×   10  5  /well) 
were pretreated with or without ACs for 3 h, washed, and stimulated with 
LPS for 72 h. Supernatants were collected and assayed for IL-12p70 in triplicate 
using an ELISA kit (BD Biosciences) following the manufacturer  ’  s instructions. 
Intracellular IL-12 staining was performed using a Cytofi  x/Cytoperm cell 
permeabilization kit (BD Biosciences) and PE-labeled anti  –  mouse IL-12p40/70. 
Alternatively, DCs were stimulated by cross-linking CD40 with 10   μ  g/ml of 
anti-CD40 IgM (HM40-3; BD Biosciences) and anti-IgM antibody (G188-2; 
BD Biosciences) for 30 min. 
  DC:T cell stimulation assay.     DCs were pretreated (or not) with ACs for 
3 h, washed, and plated in 24-well ultra-low cluster plates at 3   ×   10  4   DCs/
well. BDC CD4  +   or CL4 CD8  +   T cells (3   ×   10  5  /well) plus 0.1   μ  g/ml of the 
H2A  g7  -restricted BDC mimotope (RTRPLWVRME) or H2-K  d    –  restricted 
infl  uenza virus HA peptide (IYSTVASSL) were added, and cultures were in-
cubated for 72 h. Alternatively, varying numbers of DCs were cultured with 
10  6   BDC CD4  +   or CL4 CD8  +   T cells. Supernatants were harvested, and IL-2 
concentration was measured in triplicate by a sandwich ELISA using the 
JES6-1A12 (eBioscience), and biotinylated JES6-EH4 anti  –  IL-2 Abs, and 
streptavidin-HRP (BD Biosciences). Concentration of IL-2 was determined 
using a standard curve. Splenic BDC CD4  +   and CL4 CD8  +   T cells were pre-
pared by depleting DCs, macrophages, and B cells via magnetic cell sorting 
using anti-CD11c, anti-CD11b, and anti-CD19 antibody-magnetic micro-
beads (Miltenyi Biotec), respectively. BDC CD4  +   and CL4 CD8  +   T cells 
were then positively selected using anti-CD4 or -CD8 antibody-magnetic 
CD11b  +  F4/80  +   macrophages and CD1d tetramer-staining 
NKT cells in the PLNs of recipient mice was not aff  ected 
by DT treatment (Fig. S7, available at http://www.jem.org/
cgi/content/full/jem.20062293/DC1). 
  Our results suggest that pancreatic CD11c  +  CD8      +   DCs 
lacking MerTK expression are no longer sensitive to the in-
hibitory eff  ects of ACs. These DCs, upon encountering apop-
totic      cells, process and present antigens, but maintain the 
capacity to be activated and in turn promote      cell  –  specifi  c 
T cell reactivity. A reduced frequency of CD11c  +  CD11b  +   
DCs, which may have a protective role in NOD mice under 
certain conditions, may also indirectly promote      cell auto-
immunity in the respective models. Interestingly, specifi  c poly-
morphisms within the   MERTK   gene have been identifi  ed in 
patients with systemic lupus erythematosus (  47  ). Furthermore, 
  MERTK   and   Mertk   are located within the T1D-susceptibility 
intervals   IDDM12/13   and   Idd13   both in human populations 
and mice, respectively (  48  –  51  ). Sequence analysis of cDNAs 
encoding MerTK from a variety of mouse strains have identi-
fi  ed at least three allelic variants (unpublished data). There-
fore, it is possible that allelic variants of   MERTK   and   Mertk   
encode proteins that alter the response of DCs or other innate 
eff  ectors (i.e., macrophages and NKT cells) to ACs, leading to 
the promotion or prevention of autoimmunity. 
  Noteworthy is that, despite a periphery that is   “  proinfl  am-
matory  ”   (  Figs. 6  –  8  ), NOD.MerTK  KD/KD   female (and male) 
mice remain diabetes-free. This is caused by increased effi   -
ciency of thymic negative selection in NOD.MerTK  KD/KD   
mice and eff  ective purging of the      cell  –  specifi  c T cell rep-
ertoire (unpublished data). Consequently, insulitis is signifi  -
cantly reduced, and NOD.MerTK  KD/KD   mice fail to develop 
diabetes. In marked contrast, BDC clonotypic thymocytes in 
NOD.MerTK  KD/KD  .BDC mice are not deleted, and the high 
frequency of mature T cells that enter the periphery readily 
diff  erentiate into pathogenic eff  ectors and drive      cell auto-
immunity (  Fig. 5 A  ). Similarly, transferred BDC CD4  +   T cells 
proliferate and diff  erentiate into type 1 eff  ectors in STZ-
treated NOD.MerTK  KD/KD  , but not NOD recipients (  Fig. 6  ). 
Together, these fi  ndings suggest that MerTK infl  uences the 
  “  normal  ”   progression of      cell autoimmunity in at least two 
mutually nonexclusive ways: (a) in the thymus, by regulating 
the effi   ciency of negative selection by thymic DCs, and (b) in 
the periphery, by eff  ecting DC responses to ACs and in turn 
infl  uencing the general proinfl  ammatory milieu. Eff  orts are 
ongoing to further defi  ne the roles of MerTK in T1D. In sum-
mary, our fi  ndings demonstrate that MerTK is necessary for 
establishing T cell tolerance to AC-expressed proteins, and 
that altered function of this RTK may, in addition to T1D, 
contribute to other T cell  –  mediated autoimmune diseases. 
    MATERIALS AND METHODS   
  Mice.     NOD/LtJ (NOD), NOD.Cg-Tg(TcraBDC2.5)1Doi Tg(TcrbBDC2.5)
2Doi (NOD.BDC), NOD-Tg(TcraCl4, TcrbCl4; NOD.CL4), and BALB/c 
mice were maintained and bred under specifi  c-pathogen free conditions. 
Establishment of NOD.MerTK  KD/KD   mice has been described (  22  ). The 
CD11c-DTR transgene (  32  ) was backcrossed 13 generations onto the NOD 
genetic background; NOD.DTR mice develop diabetes at a similar time of 230 IMMUNOREGULATION OF DENDRITIC CELLS | Wallet et al.
5:1 for 6 h at 37 or 4  °  C. Alternatively, NOD BMDCs were pretreated with 
10   μ  g of anti-MerTK or isotype control antibody before AC pretreatment. 
Cells were then cultured for 10 min in PBS with 2 mM EDTA and washed 
vigorously to remove noningested but bound AC, which was confi  rmed by 
confocal microscopy. BMDCs were stained with anti  –  CD11c-APC and 
analyzed for ingestion of fl  uorescent ACs by FACS. 
  In vivo AC clearance assay.     Mice received a single i.p. injection of 
120 mg/kg STZ in citrate saline. Pancreases were harvested and digested 
with collagenase, and islets were isolated (  53  ). Purifi  ed islets were dissoci-
ated in PBS, plus 2 mM EDTA for 20 min at room temperature, followed 
by vigorous pipetting. Islet cells were fi  xed in 70% ethanol, permeabilized 
with 0.1% Triton X-100, and stained with propidium iodide. Cells were 
analyzed for DNA content by FACS, and subdiploid cells were considered 
to be apoptotic. 
  Online supplemental material.     Fig. S1 demonstrates surface expression 
of MerTK on BMDCs and sDCs. Fig. S2 shows that antibody blockade of 
MerTK on BALB/c BMDCs prevents AC-induced inhibition. Fig. S3 demon-
strates that protein S has no role in AC-induced inhibition. Fig. S4 shows 
Gas6 surface expression on apoptotic      cells. Fig. S5 shows that no signifi  -
cant diff  erence exists in in vivo clearance of apoptotic      cells in NOD and 
NOD.MerTK  KD/KD   mice. Fig. S6 demonstrates that MerTK is not required 
for AC phagocytosis by BMDCs. Fig. S7 shows that DT treatment of NOD.
MerTK.DTR mice depletes DCs but not macrophages or NKT cells in the 
PLN. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20062293/DC1. 
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